rs117642173
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_004260.4(RECQL4):c.1391-1G>A variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.0000526 in 1,596,570 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_004260.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- Baller-Gerold syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
- Rothmund-Thomson syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Rothmund-Thomson syndrome type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- osteosarcomaInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- rapadilino syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RECQL4 | ENST00000617875.6 | c.1391-1G>A | splice_acceptor_variant, intron_variant | Intron 7 of 20 | 1 | NM_004260.4 | ENSP00000482313.2 | |||
| RECQL4 | ENST00000621189.4 | c.320-1G>A | splice_acceptor_variant, intron_variant | Intron 6 of 19 | 1 | ENSP00000483145.1 | ||||
| RECQL4 | ENST00000532846.2 | c.275-1G>A | splice_acceptor_variant, intron_variant | Intron 3 of 8 | 5 | ENSP00000476551.1 | ||||
| RECQL4 | ENST00000688394.1 | n.414-1G>A | splice_acceptor_variant, intron_variant | Intron 1 of 3 |
Frequencies
GnomAD3 genomes AF: 0.0000525 AC: 8AN: 152238Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000361 AC: 8AN: 221684 AF XY: 0.0000415 show subpopulations
GnomAD4 exome AF: 0.0000526 AC: 76AN: 1444214Hom.: 0 Cov.: 34 AF XY: 0.0000474 AC XY: 34AN XY: 717086 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152356Hom.: 0 Cov.: 34 AF XY: 0.0000537 AC XY: 4AN XY: 74500 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Rothmund-Thomson syndrome type 2 Pathogenic:2
- -
- -
not provided Pathogenic:1
RECQL4: PVS1, PM2, PM3, PP1 -
Baller-Gerold syndrome Pathogenic:1
This sequence change affects an acceptor splice site in intron 7 of the RECQL4 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in RECQL4 are known to be pathogenic (PMID: 12734318, 12952869). This variant is present in population databases (rs117642173, gnomAD 0.009%). Disruption of this splice site has been observed in individual(s) with Rothmund–Thomson syndrome (PMID: 10678659, 21143835, 27247962, 28039508, 28486640). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as a 3' splice site G→A change. ClinVar contains an entry for this variant (Variation ID: 6067). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at